Zhao et al. found that curcumin as an active component of Chinese medicine, reduced FOXO1 phosphorylation by inhibiting the PI3K/Akt signaling pathway, thus maintaining FOXO1 transcriptional activity to inhibit pancreatic cancer cell proliferation [29]. Here, FOXO1 is linked to familial pancreatic carcinoma.